M&A Deal Summary |
|
|---|---|
| Date | 2000-01-17 |
| Target | SmithKline Beecham |
| Sector | Life Science |
| Buyer(s) | GSK |
| Deal Type | Merger |
| Deal Value | 75.7B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 35 |
| Sector: Life Science M&A | 2 of 28 |
| Type: Merger M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 5 |
| Year: 2000 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-02-09 |
Diversified Pharmaceutical Services
St. Louis, Montana, United States Diversified Pharmaceutical Services, Inc.is a provider of pharmaceutical benefit management services. |
Sell | $700M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2001-01-16 |
Block Drug Company
Jersey City, New Jersey, United States Block Drug Company is a pharmaceutical company specializing in dental care products. |
Buy | $1.2B |
